Review



gclc  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Proteintech gclc
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gclc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 135 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc/product/Proteintech
    Average 96 stars, based on 135 article reviews
    gclc - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Thonningianin A derived from Penthorum chinense Pursh alleviates cerebral ischemia/reperfusion-mediated apoptosis and pyroptosis through the activation of PINK1/Parkin-dependent mitophagy"

    Article Title: Thonningianin A derived from Penthorum chinense Pursh alleviates cerebral ischemia/reperfusion-mediated apoptosis and pyroptosis through the activation of PINK1/Parkin-dependent mitophagy

    Journal: Chinese Medicine

    doi: 10.1186/s13020-025-01247-2

    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Figure Legend Snippet: TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group

    Techniques Used: Staining, Fluorescence, Incubation, Laser-Scanning Microscopy, MTT Assay, Expressing, Western Blot



    Similar Products

    gene exp gclc rn00689046 m1  (Thermo Fisher)
    85
    Thermo Fisher gene exp gclc rn00689046 m1
    Gene Exp Gclc Rn00689046 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp gclc rn00689046 m1/product/Thermo Fisher
    Average 85 stars, based on 1 article reviews
    gene exp gclc rn00689046 m1 - by Bioz Stars, 2026-03
    85/100 stars
    		  Buy from Supplier
    gclc  (Proteintech)
    96
    Proteintech gclc
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gclc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc/product/Proteintech
    Average 96 stars, based on 1 article reviews
    gclc - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    glutamate cysteine ligase catalytic subunit gclc  (Proteintech)
    96
    Proteintech glutamate cysteine ligase catalytic subunit gclc
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Glutamate Cysteine Ligase Catalytic Subunit Gclc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutamate cysteine ligase catalytic subunit gclc/product/Proteintech
    Average 96 stars, based on 1 article reviews
    glutamate cysteine ligase catalytic subunit gclc - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    glutamate cysteine ligase catalytic subunit  (Proteintech)
    96
    Proteintech glutamate cysteine ligase catalytic subunit
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Glutamate Cysteine Ligase Catalytic Subunit, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutamate cysteine ligase catalytic subunit/product/Proteintech
    Average 96 stars, based on 1 article reviews
    glutamate cysteine ligase catalytic subunit - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    gene exp gclc hs00155249 m1  (Thermo Fisher)
    98
    Thermo Fisher gene exp gclc hs00155249 m1
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gene Exp Gclc Hs00155249 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp gclc hs00155249 m1/product/Thermo Fisher
    Average 98 stars, based on 1 article reviews
    gene exp gclc hs00155249 m1 - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    gene exp gclc mm00802655 m1  (Thermo Fisher)
    98
    Thermo Fisher gene exp gclc mm00802655 m1
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gene Exp Gclc Mm00802655 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp gclc mm00802655 m1/product/Thermo Fisher
    Average 98 stars, based on 1 article reviews
    gene exp gclc mm00802655 m1 - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group

    Journal: Chinese Medicine

    Article Title: Thonningianin A derived from Penthorum chinense Pursh alleviates cerebral ischemia/reperfusion-mediated apoptosis and pyroptosis through the activation of PINK1/Parkin-dependent mitophagy

    doi: 10.1186/s13020-025-01247-2

    Figure Lengend Snippet: TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group

    Article Snippet: Antibodies against GSDMD (20770-1-Ap), Caspase-3 (25158-1-Ap), Caspase-9 (10380-1-Ap), NQO1 (11451-1-Ap), GCLC (12601-1-Ap), LC3 (14600-1-Ap), PINK1 (23274-1-Ap), Parkin (14060-1-Ap), Antibody Caspase-1 (22,915-1-ap), GAPDH (6004-1-Ig), β-actin (66009-1-Ig), CoraLite ® Plus 488 goat anti-rabbit IgG (RGAR002), CoraLite ® Plus 594-Goat Anti-Mouse IgG (RGAR002), were purchased from Proteintech Group, Inc (Wuhan, China).

    Techniques: Staining, Fluorescence, Incubation, Laser-Scanning Microscopy, MTT Assay, Expressing, Western Blot